• Perospirone Inhibits Kv1.5 Channels: Cardiovascular Implicat

  2026-07-06

  The reference study identifies a novel off-target action of Perospirone (SM-9018 free base), demonstrating concentration-dependent inhibition of vascular Kv1.5 channels in coronary arterial smooth muscle. These findings extend the mechanistic understanding of this atypical antipsychotic, suggesting a potential link between its neuropsychiatric applications and cardiovascular effects.

• Olaparib (AZD2281): Synergistic DNA Repair Disruption in Can

  2026-07-06

  Explore how Olaparib (AZD2281) advances DNA damage response research by enabling synergistic targeting of cancer cell repair pathways. This article uncovers new mechanistic insights for BRCA-associated cancer therapy and radiosensitization studies.

• BV6 IAP Antagonist: Applied Workflows for Cancer Research

  2026-07-05

  BV6 is transforming apoptosis induction in cancer cells and endometriosis models by selectively targeting IAPs and enhancing radiosensitization. This article details hands-on protocols, troubleshooting, and strategic integration for maximizing BV6's translational impact.

• Losmapimod (GW856553X): Precision p38 MAPK Inhibition Workfl

  2026-07-04

  Losmapimod (GW856553X) stands out as a dual-action p38 MAPK inhibitor, uniquely enhancing both kinase inhibition and phosphatase-mediated dephosphorylation. Applied across vascular and inflammation models, it delivers reproducible, high-sensitivity results—especially when protocol nuances and troubleshooting strategies are integrated from the latest mechanistic studies.

• BMN 673 (Talazoparib): Precision Tool for DNA Repair Deficie

  2026-07-03

  BMN 673 (Talazoparib) sets a new benchmark for targeting homologous recombination-deficient cancers, offering unmatched PARP-DNA complex trapping and selectivity. This article provides actionable guidance for maximizing its research value, integrating insights from recent mechanistic breakthroughs and experimental workflows.

• CLCC1 Identified as Host Factor in Herpesvirus Nuclear Egres

  2026-07-03

  A recent study has revealed that the chloride channel CLCC1 is essential for the membrane fusion step of herpesvirus nuclear egress, a process critical for viral replication. This finding not only clarifies a longstanding gap in herpesvirus cell biology but also highlights potential host-targeted strategies for antiviral intervention.

• Radicicol: Hsp90 Inhibitor for Advanced Cell and Inflammatio

  2026-07-02

  Radicicol is a multipotent Hsp90 inhibitor that enables precise dissection of adipogenesis, apoptosis, and inflammatory pathways. Its robust ATPase inhibition and workflow flexibility make it indispensable for adipocyte differentiation, ovarian carcinoma apoptosis, and sepsis inflammation models.

• BMN 673 (Talazoparib): Mechanistic Insights for Precision DN

  2026-07-02

  Explore the unique mechanism and advanced applications of BMN 673 (Talazoparib), a potent PARP1/2 inhibitor, in DNA repair deficiency targeting. This in-depth analysis reveals how recent mechanistic discoveries inform assay design and translational research.

• Anlotinib Hydrochloride: Translational Strategies for Advanc

  2026-07-01

  Explore the mechanistic, pharmacological, and translational foundations of Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor. This article delivers protocol insights, comparative analyses, and practical considerations for cancer research, uniquely connecting molecular selectivity with real-world assay design.

• Imatinib Hydrochloride: Optimized Workflows for Cancer Resea

  2026-07-01

  Imatinib hydrochloride (STI571 hydrochloride) is a gold-standard tyrosine kinase inhibitor, enabling precise interrogation of v-Abl, c-Kit, and PDGFR pathways in both chronic myelogenous leukemia and GIST research models. This guide translates dual-action kinase inhibition advances into actionable protocols, troubleshooting strategies, and workflow enhancements for reproducible, high-impact results.

• Anlotinib Hydrochloride: Selective VEGFR2 Inhibition in Tumo

  2026-06-30

  The reference study characterizes anlotinib hydrochloride as a highly potent and selective VEGFR2 inhibitor with significant anti-angiogenic and anti-tumor efficacy in preclinical models. Its ability to suppress endothelial cell migration, capillary tube formation, and in vivo tumor vascularization highlights its translational value for cancer research.

• PARP1/FAK/COL5A1 Axis Drives EMT in Cholesterol-Resistant Ov

  2026-06-30

  This study reveals that persistent high cholesterol promotes ovarian cancer progression by activating a PARP1/FAK/COL5A1 signaling cascade, which enhances epithelial-mesenchymal transition (EMT) and tumorigenesis. These mechanistic insights offer a new rationale for targeting FAK and its downstream effectors in models of cholesterol-resistant ovarian cancer.

• Entinostat (MS-275): Protocol-Driven HDAC1/3 Inhibition in C

  2026-06-29

  Entinostat (MS-275) enables precise, reproducible HDAC1/3 inhibition, unlocking epigenetic modulation in both cancer biology and regenerative research. This guide translates recent mechanistic discoveries and protocol optimizations into actionable workflows for robust, data-rich experimentation.

• E-64d: Applied Cysteine Protease Inhibition for Cell Fate St

  2026-06-29

  E-64d empowers researchers to dissect regulated cell death, offering membrane-permeable, irreversible cysteine protease inhibition in both cellular and in vivo models. Explore optimized workflows, troubleshooting strategies, and comparative advantages for apoptosis, lysoptosis, and neuroprotection studies.

• Moxidectin Enhances Polyene Antifungal Action via Ergosterol

  2026-06-28

  A 2024 study demonstrates that moxidectin, traditionally a macrocyclic lactone anthelmintic, elevates ergosterol biosynthesis in Candida albicans, synergizing with polyene antifungals to suppress oral candidiasis. This mechanistic insight opens new experimental strategies to overcome current antifungal limitations in both clinical and laboratory settings.

16660 records 1/1111 page Next 12345 下5页 Last page